Literature DB >> 22545762

Efficacy of codelivery of dual AAV2/5 vectors in the murine retina and hippocampus.

Arpad Palfi1, Naomi Chadderton, Alex G McKee, Alfonso Blanco Fernandez, Peter Humphries, Paul F Kenna, G Jane Farrar.   

Abstract

Recombinant adeno-associated virus (AAV) represents an efficient system for neuronal transduction. However, a potential drawback of AAV is its restricted packaging capacity of approximately 5 kb. To bypass this limitation, a number of dual- and triple-vector strategies divide the transgene(s) between two or three AAVs. The success of these approaches relies directly on efficient cotransduction of the component AAVs. Although proof of concept for these stratagems has been demonstrated, the underlying cotransduction rate has not been analyzed quantitatively. In this study, cotransduction efficiencies in both retina and hippocampus have been investigated, using two reporter AAVs expressing either a green (GFP) or red (DsR) fluorescent protein. Transduction efficiencies were monitored via microscopy, flow cytometry, and quantitative PCR. After viral transduction with 1.5×10(9) viral particles of each of the reporter AAVs, approximately one-third of the retinal cells expressed one or both transgenes at levels detectable by native fluorescence. Notably, the majority of the remaining retinal cells were also transduced and expressed the reporters at lower levels, which were detectable only by immunolabeling. Flow cytometric analysis demonstrated cotransduction rates of up to 55% with the two reporter AAVs in retinal cells. Modifying the ratio of the two coadministered AAVs resulted in altered mRNA expression levels of the two reporter genes in cotransduced cell populations. The study suggests that codelivery of AAV is an efficient means of expanding the therapeutic application of AAV in neurons.

Entities:  

Mesh:

Year:  2012        PMID: 22545762     DOI: 10.1089/hum.2011.142

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  15 in total

1.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

Review 2.  Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.

Authors:  Kyle Chamberlain; Jalish Mahmud Riyad; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2016-02       Impact factor: 2.396

3.  Copackaging of multiple adeno-associated viral vectors in a single production step.

Authors:  Phillip A Doerfler; Barry J Byrne; Nathalie Clément
Journal:  Hum Gene Ther Methods       Date:  2014-09-19       Impact factor: 2.396

Review 4.  Optical stimulation for restoration of motor function after spinal cord injury.

Authors:  Grant W Mallory; Peter J Grahn; Jan T Hachmann; J Luis Lujan; Kendall H Lee
Journal:  Mayo Clin Proc       Date:  2015-02       Impact factor: 7.616

Review 5.  Gene therapy for retinal disease.

Authors:  Michelle E McClements; Robert E MacLaren
Journal:  Transl Res       Date:  2013-01-08       Impact factor: 7.012

6.  Viral Vector Technologies and Strategies: Improving on Nature.

Authors:  Roxanne H Croze; Melissa Kotterman; Christian H Burns; Chris E Schmitt; Melissa Quezada; David Schaffer; David Kirn; Peter Francis
Journal:  Int Ophthalmol Clin       Date:  2021-07-01

Review 7.  Delivering AAV to the Central Nervous and Sensory Systems.

Authors:  Cole W Peters; Casey A Maguire; Killian S Hanlon
Journal:  Trends Pharmacol Sci       Date:  2021-04-13       Impact factor: 17.638

8.  Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model.

Authors:  Da Sun; Wenyu Sun; Song-Qi Gao; Cheng Wei; Amirreza Naderi; Andrew L Schilb; Josef Scheidt; Sangjoon Lee; Timothy S Kern; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  J Control Release       Date:  2020-12-21       Impact factor: 11.467

9.  Gene expression changes during retinal development and rod specification.

Authors:  Fiona C Mansergh; Matthew Carrigan; Karsten Hokamp; G Jane Farrar
Journal:  Mol Vis       Date:  2015-01-20       Impact factor: 2.367

10.  Effective delivery of large genes to the retina by dual AAV vectors.

Authors:  Ivana Trapani; Pasqualina Colella; Andrea Sommella; Carolina Iodice; Giulia Cesi; Sonia de Simone; Elena Marrocco; Settimio Rossi; Massimo Giunti; Arpad Palfi; Gwyneth J Farrar; Roman Polishchuk; Alberto Auricchio
Journal:  EMBO Mol Med       Date:  2013-12-15       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.